Current Topics in Medicinal Chemistry

Editor-in-Chief

Jia Zhou
Chemical Biology Program
Department of Pharmacology and Toxicology
University of Texas Medical Branch
Galveston, TX
(USA)

Personal Subscription
Become EABM
Become Reviewer
Call for Editor
Volume: 2 Issue: 12, December

Preface

Volume:2   Issue: 12
Pp: i-i
Asim K. Debnath
DOI: 10.2174/1568026023392904
Published on: 01 March, 2012

Predicting Drug-Likeness: Why and How ?

Volume:2   Issue: 12
Pp: 1273-1286
Ajay
DOI: 10.2174/1568026023392968
Published on: 01 March, 2012

In Silico and Ex Silico ADME Approaches for Drug Discovery

Volume:2   Issue: 12
Pp: 1287-1304
Ferenc Darvas, Gyorgy Keseru, Akos Papp, Gyorgy Dorman, Laszlo Urge and Peter Krajcsi
DOI: 10.2174/1568026023392841
Published on: 01 March, 2012

Retrospect and Prospect of Virtual Screening in Drug Discovery

Volume:2   Issue: 12
Pp: 1305-1320
Huafeng Xu and Dimitris K. Agrafiotis
DOI: 10.2174/1568026023392869
Published on: 01 March, 2012

History and Evolution of the Pharmacophore Concept in Computer-Aided Drug Design

Volume:2   Issue: 12
Pp: 1321-1332
Osman F. Guner
DOI: 10.2174/1568026023392940
Published on: 01 March, 2012

The Present Utility and Future Potential for Medicinal Chemistry of QSAR / QSPR with Whole Molecule Descriptors

Volume:2   Issue: 12
Pp: 1333-1356
Alan R. Katritzky, Dan C. Fara, Ruslan O. Petrukhin, Douglas B. Tatham, Uko Maran, Andre Lomaka and Mati Karelson
DOI: 10.2174/1568026023392922
Published on: 01 March, 2012

QSAR: Then and Now

Volume:2   Issue: 12
Pp: 1357-1379
C. D. Selassie, S. B. Mekapati and R. P. Verma
DOI: 10.2174/1568026023392823
Published on: 01 March, 2012

Current State and Perspectives of 3D-QSAR

Volume:2   Issue: 12
Pp: 1381-1394
Miki Akamatsu
DOI: 10.2174/1568026023392887
Published on: 01 March, 2012